Navigation Links
Study looks at new bladder cancer therapy for patients unresponsive to standard treatment
Date:2/26/2008

NEW YORK (Feb. 26, 2008) -- As many as half of patients with superficial bladder cancer do not respond to the standard first-line chemotherapy placed into the bladder, according to current multi-center outcomes data. When this happens, typically, their only option is surgical removal of the bladder. Now, researchers at the Herbert Irving Comprehensive Cancer Center of NewYork-Presbyterian Hospital and Columbia University Medical Center are investigating an FDA-approved metastatic breast-cancer drug called Abraxane that may prove a safe and effective alternative to surgery for these patients.

Bladder cancer is the fourth leading cause of cancer in men and the ninth leading cause of cancer in women in the United States. In a given year, more than 60,000 new cases are diagnosed, and 13,000 will die from the disease.

"When the standard treatment does not work, currently the only option is surgical removal of the bladder -- something that, for all patients, is unappealing, and for some sicker patients is not even possible. With this study, we hope to find an effective second line medical option for these patients," says Dr. James McKiernan, director of urologic oncology at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital and Columbia University Medical Center, and vice chairman of the Department of Urology and assistant professor of urology at Columbia University College of Physicians and Surgeons.

The Phase I/II study will follow 18 patients for six weeks to assess dosage safety, followed by a second group of 19 patients who will be followed for six weeks to measure the effectiveness of the therapy.

The study is open to patients with recurrent bladder cancer that has not responded to standard therapy -- BCG (bacillus Calmette-Guerin) treatment.

In 2006, Dr. McKiernan, together with departmental chair Dr. Mitchell C Benson, led a phase I study of the drug Taxotere, also used to treat breast
'/>"/>

Contact: Jennifer Homa
jeh9057@nyp.org
212-305-5587
New York- Presbyterian Hospital/Columbia University Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. LSU researchers study coastal community bounce back
2. Childrens Hospital 1 of 10 pediatric hospitals in US selected to study liver disease in kids
3. Yoga Journal Releases 2008 Yoga in America Market Study
4. Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study
5. Study finds recent trend of growing US disparities in health not inevitable
6. LA BioMed study finds hormone therapy increases frequency of abnormal mammograms, breast biopsies
7. Faux Fido eases loneliness in nursing home residents as well as real dog, SLU study finds
8. Study details link between obesity, carbs and esophageal cancer
9. Interactive Patient Television Drives Patient Satisfaction, LodgeNet Healthcare Study Shows
10. Trial finds tenofovir gel safe for daily use and most women adhered to study regimens
11. Study finds spine surgery yields greater benefits over nonsurgical treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... IQ Formulations , a top national ... Inc. 500 , distinguishing it as one of the ... not only made the list, but was ranked in the ... past three years. It also ranked ninth among all health ... the second fastest growing company in the Miami metro area. ...
(Date:8/20/2014)... August 20, 2014 It’s no secret ... According to the National Institute on Drug Abuse, nearly ... drugs. What’s even more alarming is the fact that ... last decade. , Those locked in a struggle with ... way out. But now, the newly-redesigned AbuseTreatmentCenters.net has released ...
(Date:8/20/2014)... New York, NY (PRWEB) August 20, 2014 ... the world’s largest nutrition school, is proud to ... of Integral Studies (CIIS), a cutting-edge university ... Integrative Nutrition’s Health Coach Training Program are now ... Master of Arts in Integrative Health Studies. , ...
(Date:8/20/2014)... federal judge has remanded a lawsuit filed by a group ... to the City of St. Louis Circuit Court, reports the ... an assertion by the defendants that the plaintiffs’ claims should ... Fresenius Medical Care North America Inc., et al., No. 4:14-967) ... the dialysis products GranuFlo and NaturaLyte. In 2012, the U.S. ...
(Date:8/20/2014)... Clearwater, FL (PRWEB) August 20, 2014 ... their first-ever stem cell facial. Utilizing the new ... anti-aging treatment effectively targets fine lines and wrinkles ... recently announced August specials, highlighting the new service ... the purchase of the stem cell facial. , ...
Breaking Medicine News(10 mins):Health News:Leading Health Supplement Company IQ Formulations Among Inc. Magazine’s Top 50 Fastest Growing Private Companies in the United States 2Health News:Re-Launched AbuseTreatmentCenters.net Offering New List of Substance Abuse Resources 2Health News:Integrative Nutrition Announces New Partnership with California Institute of Integral Studies 2Health News:Integrative Nutrition Announces New Partnership with California Institute of Integral Studies 3Health News:GranuFlo/NaturaLyte Case Remanded to State Court By Missouri Federal Judge, Baron and Budd Reports 2Health News:New Stem Cell Facial Unveiled at Botanica Day Spa 2Health News:New Stem Cell Facial Unveiled at Botanica Day Spa 3
... Helping Infertile Men and Women Find the Solutions to their Infertility ... Through Technology. , ... (PRWEB) May 16, 2009 -- ... couples that are struggling to be pregnant. National Fertility Link helps ...
... developments, The Villa Group encourages travelers to take advantage ... CDC today removed the Travel Health Warning against ... health safety. SAN DIEGO, May 15 In their ... in Mexico, CDC has noted that the virus activity ...
... cancer registriesone featuring transplant patients and the other the ... found that transplant patients experience worse outcomes from cancer. ... May 15, 2009, edition of the journal Transplantation ... MD, PhD, Jason Everly, PharmD, Steve Woodle, MD, and ...
... in Healthcare Technology Initiatives, Selected as Advisor to ... May 15 Cleveland Clinic Chief Information Officer ... to the U.S. Department of Health and Human ... of 23 experts appointed to the federal advisory ...
... Mass., May 15 Boston Scientific Corporation (NYSE: ... PCR Post-Op Summit in London.Jim Tobin, President and Chief Executive ... on Friday, May 22, beginning at approximately 9:30 a.m. London ... be available to all interested parties at Boston Scientific,s website ...
... 15 Herbal dietary supplement sales in the United ... figure of $4,800,000,000. A recent report published in the ... , based on data from multiple market research firms, ... 1% over 2007 sales.The HerbalGram report features ...
Cached Medicine News:Health News:Fewer Than One Percent of Infertile Couples Who Need Treatment Receive It - Website to Bridge Gap Between Infertile Couples and Fertility Clinics 2Health News:Fewer Than One Percent of Infertile Couples Who Need Treatment Receive It - Website to Bridge Gap Between Infertile Couples and Fertility Clinics 3Health News:Centers for Disease Control Lifts Travel Health Warning for Mexico 2Health News:Transplant patients have worse cancer outcomes, analysis shows 2Health News:Cleveland Clinic CIO Named to Federal Advisory Committee on Health Information Technology 2Health News:Herbal Supplement Sales Increase in US in 2008 2Health News:Herbal Supplement Sales Increase in US in 2008 3Health News:Herbal Supplement Sales Increase in US in 2008 4
(Date:8/19/2014)... Aug. 19, 2014   Lincor Inc. ... experience technology to New Jersey ... agreement, CarePoint Health will deploy Lincor,s PatientLINC technology ... Christ Hospital and Hoboken University Medical Center. ... of software solutions to help hospitals reach new ...
(Date:8/19/2014)... 19, 2014 Minimally Invasive Devices Inc. (MID), ... company, announced today that Mitsubishi Corporation has formally agreed ... system in Japan . MID anticipates ... Japan in the second half of ... distributor for Karl Storz GMBH & Co. (endoscopic instruments ...
(Date:8/19/2014)... , Aug. 19, 2014  Tokyo-based Atonarp Inc. ... funding round led by Walden Riverwood Ventures with ... development of Atonarp,s Smart Spectrometer technology platform, which ... company has targeted the oil & gas and ... "We are excited to partner with Atonarp in ...
Breaking Medicine Technology:Lincor Announces Agreement With CarePoint Health For State-Of-The-Art Patient Engagement Technology 2Minimally Invasive Devices and Mitsubishi Medical Japan Forge Exclusive Distribution Agreement 2Atonarp Inc. Raises $8M Series A Round Led by Walden Riverwood Ventures 2
... LLC (Berg) and GNS Healthcare, Inc. (GNS), a subsidiary ... into a joint venture named MAP Biosystems, LLC (MAP) ... critical biomedical research.  MAP will utilize a combination of ... and GNS,s patented supercomputer-driven REFS™ modeling and ...
... March 2, 2011 Accumetrics, Inc., a privately-held developer ... and easy-to-use point-of-care diagnostic system for measuring platelet reactivity ... has signed an agreement with Portola Pharmaceuticals, Inc. to ... use in clinical trials. The VerifyNow System ...
Cached Medicine Technology:Berg Biosystems and GNS Healthcare Announce Joint Venture - MAP Biosystems 2Berg Biosystems and GNS Healthcare Announce Joint Venture - MAP Biosystems 3Accumetrics Signs Development & Supply Agreement With Portola Pharmaceuticals, Inc. 2
Force 1C has a streamlined, compact design perfect for the requirements of outpatient surgery - as well as the power and performance features needed for a full range of general inpatient surgical pro...
Diamond phaco knife keratome shaped blade straight. 3.2 mm wide....
... Excaliburplus PC, 100V, 50Hz/60Hz is the most ... V PTP in spray Coag. It is the ... power settings from the surgical field with a ... Output Voltage in CUT maintains minimum necessary voltage ...
The Valleylab Surgistat II generator provides exceptional performance, reliability, and safety benefits in a compact, easy to use unit....
Medicine Products: